Retrovirally engineered T-cell-based immunotherapy targeting type III variant epidermal growth factor receptor, a glioma-associated antigen.

Source:http://linkedlifedata.com/resource/pubmed/id/20880333

Download in:

View as

General Info

PMID
20880333